- Home
- MRNA vs USFD Comparison
MRNA vs USFD Comparison
Compare MRNA & USFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | USFD |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 24.0B |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MRNA | USFD |
|---|---|---|
| Price | $63.63 | $110.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $34.27 | ★ $103.64 |
| AVG Volume (30 Days) | ★ 4.9M | 2.4M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.77 | ★ 45.54 |
| EPS | N/A | ★ 1.76 |
| Revenue | $19,263,000,000.00 | ★ $39,424,000,000.00 |
| Revenue This Year | $9.36 | $7.63 |
| Revenue Next Year | $15.43 | $3.92 |
| P/E Ratio | ★ N/A | $62.80 |
| Revenue Growth | ★ 4.29 | 4.08 |
| 52 Week Low | $22.28 | $69.88 |
| 52 Week High | $85.60 | $110.63 |
Technical Indicators
Market Signals| Indicator | MRNA | USFD |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 72.91 |
| Support Level | $45.69 | $88.34 |
| Resistance Level | $85.60 | N/A |
| Average True Range (ATR) | 3.68 | 2.90 |
| MACD | 0.69 | 1.05 |
| Stochastic Oscillator | 97.63 | 96.12 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About USFD US Foods Holding Corp.
US Foods is a leading domestic foodservice distributor, generating $39 billion in sales in fiscal 2025 and capturing a 10% share of the fragmented industry. The firm sells and distributes more than 350,000 food and nonfood products to about 250,000 customer locations, including independent restaurants (33% of fiscal 2025 sales), chain restaurants (23%), healthcare and hospitality clients (27%), and other end markets (17%), largely consisting of education and government contracts. US Foods also operates 98 cash-and-carry locations under the Chef'Store banner. The firm's physical network spans 76 distribution facilities and 14 broadline production centers.